Distinguished in Cutaneous T-Cell Lymphoma (CTCL)

Stephen A. Morris

Robinson Way, 
Cambridge, ENG, GB 
Distinguished in Cutaneous T-Cell Lymphoma (CTCL)
Robinson Way, 
Cambridge, ENG, GB 
OverviewLocationsClinical Research

Overview

Stephen Morris practices in Cambridge, United Kingdom. Mr. Morris is rated as a Distinguished expert by MediFind in the treatment of Cutaneous T-Cell Lymphoma (CTCL). His top areas of expertise are Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, Trabeculectomy, and Thrombectomy.

His clinical research consists of co-authoring 268 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 14 articles and participated in 2 clinical trials in the study of Cutaneous T-Cell Lymphoma (CTCL).

Gender
Male

Locations

Robinson Way, Cambridge, ENG, United Kingdom
Other Locations
170 Tottenham Court Road, W1T 7HA, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase II Trial of Pembrolizumab and Radiotherapy in Cutaneous T-cell Lymphoma
Phase II Trial of Pembrolizumab and Radiotherapy in Cutaneous T-cell Lymphoma
Enrollment Status: Active_not_recruiting
Publish Date: December 09, 2024
Intervention Type: Radiation, Drug
Study Drug: Pembrolizumab
Study Phase: Phase 2
SOLAR: A Phase 2, Randomized, Open-label, Parallel-group, Active Comparator, Multi-center Study to Investigate the Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides (MF) Subtype
SOLAR: A Phase 2, Randomized, Open-label, Parallel-group, Active Comparator, Multi-center Study to Investigate the Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Cutaneous T-Cell Lymphoma (CTCL), Mycosis Fungoides (MF) Subtype
Enrollment Status: Terminated
Publish Date: April 08, 2022
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

268 Total Publications

Cost-comparison of resequencing versus archival data methods for periodic reanalysis of genomic data in rare diseases diagnosis: A UK pilot analysis.
Cost-comparison of resequencing versus archival data methods for periodic reanalysis of genomic data in rare diseases diagnosis: A UK pilot analysis.
Journal: European journal of medical genetics
Published: August 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Morris's expertise for a condition
ConditionClose
    View All 45 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile